Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss from continuing operations	$ (39,161,000)	$ (21,462,000)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation and amortization	9,351,000	2,075,000
Stock based compensation	4,000	74,000
Gain/(loss) on equity method investment	(134,000)	2,556,000
Loss (gain) on investments	10,479,000	10,894,000
Loss on allowance for obsolescence of inventory	326,000
Change in ROU assets and lease liabilities, net	336,000
Gain on extinguishment of debt	(110,000)	(116,000)
Deferred tax benefit		(4,315,000)
Accretion of debt discount, origination fee and prepaid interest		(2,287,000)
Gain on sale of assets	(405,000)
Impairment of notes receivable and other investments	1,899,000
Decrease (increase) in assets:
Accounts receivable	(3,316,000)	829,000
Inventory	(728,000)	(1,580,000)
Prepaid expenses and other current assets	568,000	(277,000)
Other assets	(904,000)	(25,000)
Increase (decrease) in liabilities:
Accounts payable	2,128,000	432,000
Accrued expenses	(3,205,000)	1,808,000
Other liabilities	(379,000)	(1,054,000)
Net cash used by operating activities	(23,251,000)	(12,448,000)
Cash flows from investing activities:
Purchase of property, plant and equipment	(1,349,000)	(2,816,000)
Purchase of real estate	(689,000)	(6,565,000)
Purchase of investment		(19,026,000)
Purchase of marketable securities	(14,254,000)	(8,789,000)
Disposal of property, plant and equipment	2,557,000
Asset acquired with APB acquisition		1,235,000
Purchase of equity investment		(1,276,000)
Sale of marketable securities		9,185,000
Issuance of new notes receivable, net origination fees	(4,687,000)	(24,048,000)
Payments received on notes receivable	786,000
Purchase of intangible assets	(180,000)	(1,115,000)
Net cash used by investing activities	(17,816,000)	(53,215,000)
Cash flows from financing activities:
Payments of long-term debt	(561,000)	(1,893,000)
Borrowings of long-term debt	6,360,000	7,102,000
Deferred financing fees		(186,000)
Issuances of common stock, net of issuance costs	1,518,000	121,737,000
Net cash provided by financing activities	7,317,000	126,760,000
Cash flows from discontinued operations:
Cash provided by discontinued operations		207,000
Cash provided by investing activities		3,000,000
Net cash used by discontinued operations		3,207,000
Net increase (decrease) in cash	(33,750,000)	64,304,000
Cash and cash equivalents at beginning of period	56,595,000	5,183,000
Cash and cash equivalents at end of period	$ 22,845,000	$ 69,487,000